Taking into consideration the role of galectin-3 in HF, this study was planned to estimate the levels of galectin-3 in CHF patients and controls and determine the association between galectin-3 levels and age, gender, and left ventricular ejection fraction (LVEF). This evidence concerns the gene LGALS3 and hydrops fetalis.